Ingitamig

• UNSPSC Description:

  HY-P991003 is an TNFRSF17/KLRK1-targeting (G1_L-κ)_(G1-scFvkh_L-κ) type bispecific antibody[1].

• Target Antigen:

  TNF Receptor

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ingitamig.html

• Smiles:

  [Ingitamig]

• References & Citations:

  [1]INN Proposed List 131. 11 August 2024.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported